Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deletion of the government funding status notice that could indicate potential delays; this does not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:53.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page. The observed changes appear to be routine metadata updates (e.g., last update timestamps) rather than substantive edits to study content.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:08.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T10:19:34.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:20:00.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, representing a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:19.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.